[1]
Gordon, K., Warren, R.B., Gottlieb, A.B., Blauvelt, A., Tha?i, D., Leonardi, C., Poulin, Y., Boehnlein, M., Kavanagh, S., Arendt, C. and Reich, K. 2020. Certolizumab Pegol for Treatment of Plaque Psoriasis: Pooled Three-Year Efficacy Outcomes from Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2). SKIN The Journal of Cutaneous Medicine. 4, 5 (Sep. 2020), s44. DOI:https://doi.org/10.25251/skin.4.supp.44.